Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Appian
APPN
$2.18B
| $4.9M | ﹤0.01% |
36,885
+9,633
| +35% | +$1.7M |
|
1527
Emergent Biosolutions
EBS
$265M
| $4.9M | ﹤0.01% |
52,753
+11,576
| +28% | +$1.19M |
|
1528
Donaldson
DCI
$11.4B
| $4.9M | ﹤0.01% |
84,259
+59,773
| +244% | +$3.57M |
|
|
CCXI
1529
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.89M | ﹤0.01% |
95,453
+78,280
| +456% | +$4.71M |
|
|
MGLN
1530
DELISTED
Magellan Health Services, Inc.
MGLN
| $4.89M | ﹤0.01% |
52,437
+26,179
| +100% | +$2.45M |
|
1531
CareTrust REIT
CTRE
$9.74B
| $4.89M | ﹤0.01% |
209,910
+77,612
| +59% | +$1.78M |
|
1532
CVB Financial
CVBF
$4.01B
| $4.87M | ﹤0.01% |
220,622
+74,170
| +51% | +$1.61M |
|
1533
Viavi Solutions
VIAV
$10B
| $4.85M | ﹤0.01% |
308,728
+45,906
| +17% | +$741K |
|
1534
Central Garden & Pet Co Class A
CENTA
$2.47B
| $4.85M | ﹤0.01% |
116,779
+36,840
| +46% | +$1.26M |
|
1535
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.42B
| $4.83M | ﹤0.01% |
54,000
-15,800
| -23% | -$1.41M |
|
|
SAGE
1536
DELISTED
Sage Therapeutics
SAGE
| $4.83M | ﹤0.01% |
64,532
+60,523
| +1,510% | +$4.96M |
|
|
PDM
1537
Piedmont Realty Trust
PDM
$1.19B
| $4.83M | ﹤0.01% |
277,908
+204,374
| +278% | +$3.45M |
|
|
IRBT
1538
PUT
DELISTED
iRobot
IRBT
| $4.83M | ﹤0.01% |
39,500
-21,600
| -35% | -$2.46M |
|
1539
iPath Select MLP ETN
ATMP
$628M
| $4.82M | ﹤0.01% |
351,875
+100,000
| +40% | +$1.33M |
|
1540
Liberty Global Class A
LBTYA
$3.69B
| $4.81M | ﹤0.01% |
187,445
+7,378
| +4% | +$187K |
|
|
SEM
1541
DELISTED
Select Medical
SEM
| $4.8M | ﹤0.01% |
261,273
+30,164
| +13% | +$495K |
|
1542
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
| $4.8M | ﹤0.01% |
85,513
+5,013
| +6% | +$302K |
|
1543
AeroVironment
AVAV
$8.67B
| $4.79M | ﹤0.01% |
41,270
-6,733
| -14% | -$787K |
|
1544
Independent Bank
INDB
$4.02B
| $4.79M | ﹤0.01% |
56,872
+20,445
| +56% | +$1.71M |
|
1545
ManpowerGroup
MAN
$2.57B
| $4.79M | ﹤0.01% |
48,391
+38,370
| +383% | +$3.67M |
|
1546
Agios Pharmaceuticals
AGIO
$1.93B
| $4.78M | ﹤0.01% |
92,619
-18,827
| -17% | -$932K |
|
1547
AMN Healthcare
AMN
$1.21B
| $4.77M | ﹤0.01% |
64,739
-1,731
| -3% | -$129K |
|
1548
Itaú Unibanco
ITUB
$91B
| $4.77M | ﹤0.01% |
1,320,967
-1,341,604
| -50% | -$5.07M |
|
1549
Glaukos
GKOS
$10B
| $4.76M | ﹤0.01% |
56,671
+7,419
| +15% | +$652K |
|
1550
SPS Commerce
SPSC
$2.57B
| $4.76M | ﹤0.01% |
47,889
-7,299
| -13% | -$771K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.